| |
| |
|
| Insider
Information: |
Hale David F |
| Relationship: |
|
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
101,472 |
|
|
Indirect Shares
|
755,264 |
|
|
| Direct
Value |
$5,018 |
|
|
|
Indirect Value
|
$37,812 |
|
|
| Total
Shares |
856,736 |
|
|
| Total
Value |
$42,830 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
5
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
-5.0
|
| Percentage
Gain/Loss : |
 153.0%
|
 -230.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Santarus Inc |
SNTS |
Director |
2014-01-02 |
0 |
2014-01-02 |
0 |
Premium* |
|
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
Director |
2013-03-06 |
0 |
2013-03-06 |
0 |
Premium* |
|
|
Histogen Inc |
HSTO |
Director |
2014-01-08 |
24,242 |
2014-01-08 |
143,739 |
Premium* |
|
|
Biocept Inc |
BIOC |
Director |
2021-12-09 |
796 |
2021-12-09 |
101 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
Director |
2024-02-23 |
714 |
2024-02-23 |
30,590 |
Premium* |
|
|
Dermata Therapeutics, Inc. |
DRMA |
|
2022-10-06 |
75,720 |
2022-10-06 |
580,834 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
86 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DRMA |
Dermata Therapeutics, Inc... |
|
– • – |
2022-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
26,441 |
45,565 |
0 |
- |
|
| DRMA |
Dermata Therapeutics, Inc... |
|
– • – |
2022-10-06 |
4 |
A |
$0.00 |
$0 |
D/D |
30,155 |
75,720 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2024-02-23 |
4 |
B |
$9.04 |
$6,455 |
D/D |
714 |
714 |
2.39 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2024-02-23 |
4 |
B |
$9.04 |
$2,405 |
I/I |
266 |
29,673 |
2.02 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
Director |
– • – |
2010-03-22 |
5 |
GD |
$0.00 |
$0 |
I/I |
9,000 |
351,187 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
Director |
– • – |
2010-03-25 |
5 |
GD |
$0.00 |
$0 |
I/I |
600 |
350,587 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
Director |
– • – |
2010-03-29 |
5 |
GD |
$0.00 |
$0 |
I/I |
3,000 |
347,587 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
Director |
– • – |
2010-06-28 |
5 |
GD |
$0.00 |
$0 |
I/I |
1,600 |
345,987 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
Director |
– • – |
2010-12-22 |
5 |
GD |
$0.00 |
$0 |
I/I |
2,000 |
343,987 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
Director |
– • – |
2010-12-23 |
5 |
GD |
$0.00 |
$0 |
I/I |
6,000 |
337,987 |
0 |
- |
|
| SNTS |
Santarus Inc |
Director |
– • – |
2012-12-31 |
5 |
GD |
$0.00 |
$0 |
I/I |
4,000 |
300,452 |
0 |
- |
|
86 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
